Annual report pursuant to Section 13 and 15(d)

CONDENSED FINANCIAL INFORMATION OF REGISTRANT Statements of Income (Details)

v2.4.0.8
CONDENSED FINANCIAL INFORMATION OF REGISTRANT Statements of Income (Details) (USD $)
 1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Nov. 30, 2012
Aug. 31, 2012
May 31, 2012
Feb. 29, 2012
Dec. 31, 2013
Nov. 30, 2012
Nov. 30, 2011
Revenues [Abstract]                          
Lease revenue $ 857,909   $ 5,638,244 $ 5,638,244 $ 5,638,244 $ 5,638,244 $ 638,243 $ 638,244 $ 638,244 $ 638,244 $ 22,552,976 $ 2,552,975 $ 1,063,740
Sales revenue 868,992   2,351,831 1,935,868 1,929,772 2,515,573 2,216,128 1,927,626 1,439,958 2,437,310 8,733,044 8,021,022 2,161,723
Total Revenue 1,726,901 1,079,612 7,990,075 7,574,112 7,568,016 8,153,817 2,854,371 2,565,870 2,078,202 3,075,554 31,286,020 10,573,997 3,225,463
Expenses                          
Management fees, net of expense reimbursements 155,242   699,677 647,380 646,394 643,814 246,399 298,051 254,965 247,381 2,637,265 1,046,796 968,163
Asset acquisition expenses 64,733                   806,083 377,834 638,185
Professional fees 333,686                   1,678,137 1,141,045 548,759
Depreciation expense 499,357                   11,429,980 1,118,269 364,254
Amortization expense 1,967                   61,305 0 0
Directors’ fees 8,500                   178,196 85,050 70,192
Other expenses 27,500   3,880,512 4,227,013 3,845,005 3,705,925 1,117,268 1,082,911 892,759 599,865 580,183 231,086 183,674
Total Expenses 1,826,422 993,919 6,423,549 6,285,711 5,967,747 6,353,378 3,024,822 2,762,123 2,178,838 2,851,918 25,030,385 10,817,701 4,659,376
Operating Income (Loss) (99,521) 85,693 1,566,526 1,288,401 1,600,269 1,800,439 (170,451) (196,253) (100,636) 223,636 6,255,635 (243,704) (1,433,913)
Other Income (Expense)                          
Net distributions and dividend income 2,325                   584,814 (279,395) 651,673
Net realized and unrealized gain (loss) on trading securities (1,769,058)                   (251,213) 4,009,933 2,299,975
Net realized and unrealized gain (loss) on other equity securities (159,495)   1,783,460 872,020 (30,976) 2,742,049 (479,416) 8,492,502 3,237,325 8,931,466 5,617,766 16,171,944 2,283,773
Other Income 0                   0 0 40,000
Interest expense 416,137   825,588 818,134 907,275 737,381 11,705 16,780 25,229 27,409 3,288,378 81,123 36,508
Total Other Income (Expense) (2,342,365) 1,601,084 958,529 622,218 (935,550) 2,017,792 (409,064) 7,973,546 3,267,558 8,989,319 2,662,989 19,821,359 5,238,913
Income (Loss) before income taxes (2,441,886)   2,525,055 1,910,619 664,719 3,818,231 (579,515) 7,777,293 3,166,922 9,212,955 8,918,624 19,577,655 3,805,000
Taxes                          
Current tax expense 3,855,947                   13,474 29,265 253,650
Deferred tax expense (benefit) (4,776,090)                   2,936,044 7,199,669 629,207
Income tax expense (benefit), net (920,143) (628,493) 581,695 1,105,125 241,754 1,020,944 (215,927) 2,788,785 1,190,162 3,465,914 2,949,518 7,228,934 882,857
Net Income (Loss) (1,521,743) 1,058,284 1,943,360 805,494 422,965 2,797,287 (363,588) 4,988,508 1,976,760 5,747,041 5,969,106 12,348,721 2,922,143
Basic and Diluted (in dollars per share) $ (0.10)   $ 0.06 $ 0.02 $ 0.00 $ 0.10 $ (0.04) $ 0.54 $ 0.21 $ 0.63 $ 0.19 $ 1.34 $ 0.32
Basic and Diluted (in dollars per share) 15,564,861 [1]                   24,149,396 [1] 9,182,425 [1] 9,159,809 [1]
Dividends declared per share (in dollars per share) $ 0.000                   $ 0.375 $ 0.440 $ 0.410
Parent Company [Member]
                          
Revenues [Abstract]                          
Lease revenue 212,748                   2,552,976 2,552,975 1,063,740
Earnings (loss) from subsidiary (22,313)                   5,720,413 356,336 86,967
Total Revenue 190,435                   8,273,389 2,909,311 1,150,707
Expenses                          
Management fees, net of expense reimbursements 155,242                   366,863 1,046,796 968,163
Asset acquisition expenses 64,734                   806,083 377,834 638,185
Professional fees 282,303                   198,562 1,141,045 548,759
Depreciation expense 195,838                   2,463,052 837,371 294,309
Amortization expense 172                   5,320 0 0
Directors’ fees 6,000                   24,788 85,050 70,192
Other expenses 27,500                   113,001 232,248 205,795
Total Expenses 731,789                   3,977,669 3,720,344 2,725,403
Operating Income (Loss) (541,354)                   4,295,720 (811,033) (1,574,696)
Other Income (Expense)                          
Net distributions and dividend income 48,136                   6,681 261,472 786,151
Net realized and unrealized gain (loss) on trading securities (1,769,058)                   0 4,009,933 2,299,975
Net realized and unrealized gain (loss) on other equity securities (159,495)                   0 16,171,944 2,283,773
Other Income 0                   0 0 40,000
Interest expense 1,768                   (703,091) 54,661 30,203
Total Other Income (Expense) (1,882,185)                   709,772 20,388,688 5,379,696
Income (Loss) before income taxes (2,423,539)                   5,005,492 19,577,655 3,805,000
Taxes                          
Current tax expense 3,855,947                   (540,111) 29,265 253,650
Deferred tax expense (benefit) (4,776,090)                   1,043,264 7,199,669 629,207
Income tax expense (benefit), net (920,143)                   503,153 7,228,934 882,857
Net Income (Loss) $ (1,503,396)                   $ 4,502,339 $ 12,348,721 $ 2,922,143
Basic and Diluted (in dollars per share) $ 0                   $ 777,403 $ 0 $ 0
Basic and Diluted (in dollars per share) 0                   5,279,742 0 0
[1] Warrants to purchase shares of common stock were outstanding during the periods reflected in the table above, but were not included in the computation of diluted earnings per share because the warrants’ exercise price was greater than the average market value of the common shares and, therefore, the effect would be anti-dilutive.